Rezolute, Inc. — Director's Dealing 2021

Jul 28, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Rezolute, Inc. (RZLT)
CIK: 0001509261
Period of Report: 2019-01-30

Reporting Person: Genexine Inc. (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series AA Preferred Stock	$0.22		Common Stock (56818175)		Direct

Footnotes

F1: Reporting Person acquired 1,250,000 shares of Issuer's Series AA Preferred Stock on January 30, 2019. Each share of the Issuer's Series AA Preferred Stock is convertible into shares of the Issuer's Common Stock at a ratio of 45.45454 shares of Common Stock for one share of Series AA Preferred Stock ("Conversion Rate") at the holder's election and has no expiration date. The Series AA Preferred Stock will automatically convert, at the Conversion Rate, into Common Stock (i) at any time upon the vote or consent of the holders of two thirds of the voting power of the then outstanding Series AA Preferred Stock or (ii) the amendment to Issuer's Certificate of Incorporation to increase the number of shares of Common Stock authorized to be issued to at least 500,000,000 shares of Common Stock.